Northland Capital Markets Remains Bullish on Flexion Therapeutics (FLXN) After Being Granted Fast Track Status by FDA

Go back to Northland Capital Markets Remains Bullish on Flexion Therapeutics (FLXN) After Being Granted Fast Track Status by FDA
FLEXION THERAPEUT (NYSE: FLXN) Delayed: 25.07 -0.02 (0.08%)
Previous Close $25.09    52 Week High $23.57 
Open $25.07    52 Week Low $7.56 
Day High $25.07    P/E N/A 
Day Low $25.07    EPS $-2.04 
Volume 196